Application 215560
- Type
- ANDA
- Sponsor
- NOVITIUM PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATENOLOL AND CHLORTHALIDONE | ATENOLOL; CHLORTHALIDONE | TABLET;ORAL | 50MG;25MG | No | No |
| 002 | ATENOLOL AND CHLORTHALIDONE | ATENOLOL; CHLORTHALIDONE | TABLET;ORAL | 100MG;25MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 10135-733 | ATENOLOL AND CHLORTHALIDONE | atenolol and chlorthalidone tablet | MARLEX PHARMACEUTICALS, INC | ANDA | Current |
| 10135-734 | ATENOLOL AND CHLORTHALIDONE | atenolol and chlorthalidone tablet | MARLEX PHARMACEUTICALS, INC | ANDA | Current |
| 70518-3550 | Atenolol and Chlorthalidone | Atenolol and Chlorthalidone | REMEDYREPACK INC. | ANDA | Current |
| 70954-390 | Atenolol and Chlorthalidone | Atenolol and Chlorthalidone | Novitium Pharma LLC | ANDA | Current |
| 70954-391 | Atenolol and Chlorthalidone | Atenolol and Chlorthalidone | Novitium Pharma LLC | ANDA | Current |